Toggle Offcanvas
...
 
Aripiprazole Tenders

Aripiprazole Tenders

View Aripiprazole tenders, RFPs and contracts. Bid on readily available Aripiprazole tenders with the best and most comprehensive tendering platform, since 2002.
Aripiprazole is an atypical antipsychotic used to treat schizophrenia, bipolar disorder, and major depressive disorder. It works as a partial agonist at dopamine D2 and serotonin 5 HT1A receptors, helping to stabilize mood and reduce psychotic symptoms. Aripiprazole is known for its lower risk of sedation and weight gain compared to other antipsychotics.

Bidding for Aripiprazole tenders is extremely lucrative for companies of all sizes. Tendering authorities and private companies release thousands of contracts worth millions for procurement of Aripiprazole.

Global Tenders stands out as the largest platform dedicated to pharmaceutical tenders and government contracts. Boasting over 20 years of experience in the tender business, GlobalTenders offers the most extensive and reliable Tenders/RFPs/Contracts Database available. The platform aggregates contracts from both public and private sources, connecting with a vast network of over half a million buyers. Employing advanced artificial intelligence, our meticulous process involves gathering information from over a hundred thousand sources. The data is then intelligently categorized into thousands of subcategories for easy filtering and presenting it in a user-friendly format for quick comprehension.

In addition to tender information, we offer in-depth Aripiprazole market analysis, bid consultancy services, and insights into top bidders and winners.

Sign up now to get instant access to unlimited Aripiprazole tenders, advanced search filters, market analysis, industry trends, tender training and 24/7 customer support.

88 Live Notices for Aripiprazole Tenders

Showing 1 to 20

Aripiprazole Supply (Doe)
country Spain
posting date07 May 2025
deadline22 May 2025
Supply Of Medications For The Mining Hospital. Quote According To The Attached List, Annex I Which Is Part Of This Sheet. See Sheet
country Uruguay
posting date07 May 2025
deadline09 May 2025
The Object Of This Bid Is The Choice Of The Most Advantageous Proposal For The Acquisition Of Medicines For Distribution To Citizens, Through The Popular Pharmacy Of The Municipality, According To Conditions, Quantities And Requirements Established In This .
country Brazil
posting date03 May 2025
deadline02 Jun 2025
Medicines With The Active Ingredient Molizumab (Atc: R03Dx09)
country Germany
posting date15 Apr 2025
deadline31 Mar 2027
Medicines With The Active Ingredient Aripiprazole (Atc: N05Ax12 - For Parenteral Application)
country Germany
posting date10 Apr 2025
deadline31 Mar 2027
Medicines With The Active Ingredient Aripiprazole (Atc: N05Ax12 - For Parenteral Application)
country Germany
posting date10 Apr 2025
deadline31 Mar 2027
Medicines With The Active Ingredient Aripiprazole (Atc: N05Ax12 - For Parenteral Application)
country Germany
posting date10 Apr 2025
deadline31 Mar 2027
Aripiprazole Tablets 30 Mg
country Brazil
posting date28 Mar 2025
deadline07 May 2025
Open House Pharmaceutical Discounts On The Active Ingredient Aripiprazole, As A Depot Injectionsus Pension, Atc N05Ax12
country Germany
posting date13 Mar 2025
deadline28 Feb 2027
Securing Medicine Items For The Qassim University Medical City
country Saudi Arabia
posting date03 Feb 2025
deadline02 Oct 2025
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Aripiprazole For Parenteral Administration (Atc Code According To Who: N05Ax12)
country Germany
posting date23 Jan 2025
deadline31 Mar 2027
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Aripiprazole For Parenteral Administration (Atc Code According To Who: N05Ax12)
country Germany
posting date23 Jan 2025
deadline31 Mar 2027
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Aripiprazole For Parenteral Administration (Atc Code According To Who: N05Ax12)
country Germany
posting date23 Jan 2025
deadline31 Mar 2027
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V For The Active Ingredient Aripiprazole (Excl. Dafo For The Production Of A Dis), (Obo) Atc N05Ax12 For The Period 01.02.2025 - 31.01.2027
country Germany
posting date16 Dec 2024
deadline04 Dec 2026
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V For The Active Ingredient Aripiprazole (Excl. Dafo For The Production Of A Dis), (Obo) Atc N05Ax12 For The Period 01.02.2025 - 31.01.2027
country Germany
posting date16 Dec 2024
deadline04 Dec 2026
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V For The Active Ingredient Aripiprazole (Excl. Dafo For The Production Of A Dis), (Obo) Atc N05Ax12 For The Period 01.02.2025 - 31.01.2027
country Germany
posting date16 Dec 2024
deadline04 Dec 2026
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V For The Active Ingredient Aripiprazole (Excl. Dafo For The Production Of A Dis), (Obo) Atc N05Ax12 For The Period 01.02.2025 - 31.01.2027
country Germany
posting date16 Dec 2024
deadline04 Dec 2026
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V For The Active Ingredient Aripiprazole (Excl. Dafo For The Production Of A Dis), (Obo) Atc N05Ax12 For The Period 01.02.2025 - 31.01.2027
country Germany
posting date16 Dec 2024
deadline04 Dec 2026
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V For The Active Ingredient Aripiprazole (Excl. Dafo For The Production Of A Dis), (Obo) Atc N05Ax12 For The Period 01.02.2025 - 31.01.2027
country Germany
posting date16 Dec 2024
deadline04 Dec 2026
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V For The Active Ingredient Aripiprazole (Excl. Dafo For The Production Of A Dis), (Obo) Atc N05Ax12 For The Period 01.02.2025 - 31.01.2027
country Germany
posting date16 Dec 2024
deadline04 Dec 2026

Share Share this page